Chapter 7: Sexually Transmitted Infections

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually in medicine there is, there's this expectation of a warning system, like a fire alarm.

Right.

If a patient has, say, a severe respiratory infection, they're coughing, they're chest aches, they have this spiking fever.

I mean, they feel terrible.

The building is burning and the alarm is blaring so loud they just can't ignore it.

Exactly.

The symptoms are the alarm.

It's what prompts them to actually walk into the clinic.

Yeah.

And it tells us as clinicians exactly where to look.

But then you step into the world of sexually transmitted infections and suddenly it's like someone has disconnected the alarm system entirely.

Yeah, completely silent.

Right.

The building can be fully engulfed.

Like a patient can be sustaining permanent life -altering tissue damage and it is just silent.

It really is the ultimate diagnostic challenge.

And you know, that silent progression is exactly why mastering the assessment of these infections is so critical for anyone stepping into an advanced practice role.

Which is why we're here.

Welcome to this Deep Dive.

Today we are taking your advanced health assessment materials and translating those incredibly dense clinical guidelines into the exact detective skills you need on the clinic floor tomorrow.

Yeah.

We're making it practical.

Exactly.

Especially to you, the college nursing or advanced practice student who might be, you know, cramming for a clinic day or a massive exam right now.

Consider this your last minute lecture.

We are covering chapter seven, sexually transmitted infections,

going from epidemiology all the way through diagnostics, pharmacology, and ending with a real world case study.

And mastering this material is far beyond just an academic exercise for passing your boards.

Because many of these infections are entirely asymptomatic, your clinical detective work is quite literally the only thing standing between a patient and severe long -term complications.

We're talking about things like preventing pelvic inflammatory disease, right?

Right.

PID, ectopic pregnancies, and irreversible infertility.

Wow.

So before we can even diagnose a patient, we really need to understand the landscape of what we are up against.

The sheer volume of these infections is staggering.

We are looking at

approximately 26 million new infections occurring each year in the U .S.

alone.

It's massive.

And almost half of those new infections are happening in the 15 to 24 age bracket.

Yeah.

And to really assess these patients effectively, we have to look at the biological why.

Like why are the patients primarily covered in this women's health assessment uniquely vulnerable?

It comes down to anatomy, doesn't it?

It does.

People with vaginas and uberuses are biologically at a significantly greater risk of acquiring sexually transmitted infections.

Yeah.

And, you know, suffering worse consequences because of the extensive mucous membrane tissue lining the genital tract.

I always visualize that

extensive mucous membrane almost like a highly vascular porous sponge.

That's a great way to look at it.

Like it is perfectly designed for its biological and reproductive functions.

But unfortunately, that exact same environment makes it incredibly efficient at absorbing and harboring outside pathogens.

Precisely.

And when those pathogens take hold in that porous tissue, they don't just stay localized.

They ascend.

They travel up.

Right.

They travel up through the cervix into the uterus and into the delicate fallopian tubes, which is where the really catastrophic scarring and damage occurs.

So let's break down the major microscopic players you're actually going to encounter on the floor.

Chlamydia is the most common reportable STI in the U .S.

The text calls it an obligate intracellular parasite.

But what does that actually mean for the patient's body?

Well, chlamydia is essentially a biological hijacker.

Hijacker.

Yeah.

Being an obligate intracellular parasite means it cannot survive or reproduce on its own.

It has to force its way inside the host's healthy cells to steal their energy.

And because it hides inside the host's own cells, it evades the immune system incredibly well.

That is why more than half of all new cases go completely undiagnosed,

which makes it the leading cause of preventable infertility.

That is terrifying.

Then we have gonorrhea, which is a gram negative diplococcus bacteria.

It's the second most common reportable STI.

And we are seeing this really alarming trend in the

111 % increase in cases since 2009.

It's a huge spike.

And we're also seeing widespread fluoroquinolone resistance.

The bacteria are literally mutating to survive our standard antibiotic tools.

Plus, having a gonocobal infection increases a patient's susceptibility to acquiring HIV by three to five times.

Because the localized inflammation draws HIV -susceptible immune cells straight to the genital tract.

Exactly.

And then we also have to evaluate for viral infections, like genital herpes caused by HSV1 and HSV2.

It feels like viral infections are everywhere right now.

Just how prevalent are we talking when a patient comes in worried about exposure?

Well, roughly 18 .6 million Americans are infected with HSV2 alone.

Wow.

Yeah.

And we naturally look for the classic painful fluid -filled blisters during an exam.

However, the most critical clinical pearl here is that the vast majority of viral transmission happens when the patient is completely asymptomatic.

Wait, really?

Most of it?

Yes.

The virus sheds microscopically from the skin even when there is absolutely no visible lesion.

Okay.

That changes the whole screening conversation.

Yeah.

Moving on to HPV, or human papillomavirus, this is actually the most common STI overall.

Right.

About 85 % of sexually active people will acquire it at some point.

And while the infection is usually transient, you know, cleared by the immune system within two years, persistent infection with high -risk subtypes, specifically strains 16 and 18, those can integrate into the host's DNA and cause cervical cancer.

And we must also be hypervigilant about syphilis, which is caused by the treponema pallidum spiraceae.

A spiraceae.

That's the spiral one, right?

Exactly.

It's a spiral -shaped bacterium that literally corkscrews its way through tissue and mucous membranes, which allows it to enter the bloodstream very quickly.

It's known as the great imitator because symptoms mimic so many other conditions, and rates among women have spiked over 147 % recently.

Incredible.

And we round out the list with mycoplasma genitalium, which is frequently asymptomatic but strongly associated with inflammation of the cervix and

then trichomoniasis, a motile protozoan.

Right.

A tiny single cell parasite with flagella that swims.

Which is the most common curable STI known for causing a very specific frothy yellow -green discharge.

So knowing the mechanisms of these pathogens is really the foundation.

But since the alarm bells usually aren't ringing, as we said, we have to rely on deep clinical detective work.

Right.

The assessment does not start when the patient undresses for the physical exam.

It starts with a deeply targeted history.

The history dictates exactly what we will hunt for when we begin the physical evaluation.

Which is fascinating because when you look at a comprehensive review of systems for these patients,

it directs you to look far beyond the reproductive system.

Like, why am I asking a patient about a sore throat or a stiff knee when they're coming in for a pelvic exam?

Because an STI is a systemic risk, not just a localized one.

Ah, okay.

If a patient complains of a sore throat and redness in the oral cavity, that points to potential oropharyngeal gonorrhea acquired from oral sex.

If they report severe joint stiffness or swelling in their extremities, that is a massive red flag for disseminated gonococcal infection.

Meaning the bacteria has entered the bloodstream and settled in the joints.

Exactly.

And right upper quadrant abdominal pain should make you consider hepatitis or Hew -Kurtis syndrome, which is liver capsule inflammation caused by PID.

A headache or mental status changes requires an immediate evaluation for neurosyphilis.

So every single question has a biological target.

Moving into the gynecologic and sexual history, we're asking about menstrual history because abnormal bleeding, or bleeding after intercourse, can be a sign of severe cervical inflammation.

We need their contraceptive history, especially the use of IUDs and of course specific sexual behaviors.

Right.

You're gathering data on unprotected vaginal, anal and oral sex, condom use consistency, history of multiple partners.

It requires building intense rapport very quickly because you need completely honest data to determine their true risk profile.

I do want to push back or at least ask about a specific part of the history taking that often trips up students.

The personal hygiene section.

Oh yeah.

The guidelines say we need to ask about douching, bubble baths, using panty liners, tight workout clothing and wearing thong underwear because these are all associated with vaginal infections.

But how do you actually ask a patient about their underwear without sounding incredibly invasive or judgmental?

It is a very real hurdle for a clinician learning to navigate these conversations.

The key is to normalize the questions by focusing entirely on the physiological mechanics.

You could separate the behavior from any kind of morality.

Right.

You explain the why before you ask the what.

You tell the patient, the vagina maintains a very delicate balance of healthy bacteria to protect itself.

Douching physically washes that protective bacteria away, making it much easier for infections to move in.

So you make it about the micro environment.

You do.

And with clothing, you explain that tight synthetic fabrics or thong underwear create physical friction and trap moisture.

Pathogens absolutely thrive in warm, moist, dark environments.

When you frame it as an evaluation of the physical ecosystem, patients understand the medical relevance and they rarely feel judged.

That makes total sense.

So our history has given us our clues.

We know the risk factors.

Now we transition to the physical examination to find the objective evidence.

We start head to toe before we even position the patient for the pelvic exam.

You evaluate the vital signs.

A fever immediately raises the suspicion for an ascending upper tract infection like PID.

Right.

You scan their skin.

Finding a scattered, rough red or reddish brown rash on the palms of the hands or the soles of the feet is a classic hallmark sign of secondary syphilis.

Then we move to the localized pelvic exam.

First, we look externally, checking the inguinal lymph nodes for any reactive enlargement.

We visually inspect the bartholin glands, which are located at the five o 'clock and seven o 'clock positions at the vaginal opening, and the skeins glands located at the three o 'clock and nine o 'clock positions around the urethra.

We inspect those specific glands because they are highly susceptible to localized gynecoccal or chlamydial infections.

They can become obstructed, swollen, and extremely painful, sometimes even forming abscesses.

Next is the vaginal evaluation.

You have to actively displace the labial folds to fully visualize the hidden tissues.

We're assessing the discharge.

Is it creamy, clumpy, or frothy?

And this brings us to the famous amine potassium hydroxide test, better known as the WIF test.

Yes, the WIF test.

What is actually happening chemically when we do this?

Well, you take a sample of the vaginal fluid on a slide and add a drop of potassium hydroxide, or KOH.

The KOH alkalizes the fluid.

If the patient has an overgrowth of anaerobic bacteria, which is really common in bacterial vaginosis or trichomoniasis, the alkalization instantly volatilizes the amines produced by those bacteria.

And that chemical reaction releases a highly distinct foul fishy odor.

Exactly.

A positive WIF test is a major diagnostic clue.

Moving deeper, we visualize the cervix.

We're looking for mucopus, which is a purulent yellow drainage, or cervical friability.

Friability means the cervical tissue is so inflamed and engorged with blood that it bleeds easily when just lightly touched with a swab.

And that leads straight into the bimanual exam, where we palpate the uterus and surrounding adnexa.

This is where we check for cervical motion tenderness, sometimes referred to as the chandelier sign, which sounds incredibly painful.

How does a clinician handle finding this?

Well, the term chandelier sign is used because

the pain upon simply moving the cervix is so exquisite and severe that the patient reflexively pulls away or, you know, reaches for the ceiling.

Oh, wow.

Yeah.

While clinicians must always be as gentle as possible, discovering moderate to severe cervical motion tenderness is a critical diagnostic turning point.

It indicates that the infection has moved beyond the cervix and is inflamming the entire pelvic cavity.

Meaning PID.

Exactly.

If we find it, our entire management plan immediately pivots toward aggressive PID treatment to save that patient's fallopian tubes.

Okay, so we've gathered the history and we found the physical evidence, like friable tissue or a positive whiff test, but visual clues and odors aren't enough to blindly prescribe heavy antibiotics.

How do we definitively lock in the target?

We move to targeted diagnostics,

heavily utilizing the current CDC guidelines.

For screening asymptomatic patients, the standard is yearly testing for chlamydia and gonorrhea using a nucleic acid amplification test, or NAT, for all sexually active people with vaginas younger than 25 years old.

Because NATs are incredibly precise, right?

They amplify the DNA or RNA of the pathogen.

Exactly.

Now, for genital herpes, the diagnostic approach has evolved in the text.

I mean, I understand why we might use a standard culture swab for a blistering sore that's actively weeping fluid, but why the major shift toward polymerase chain reaction or PCR testing for everything else?

Well, standard cultures are like trying to identify a suspect by looking for them in a massive crowded train station.

If they happen to be hiding that day or the viral load is low, you just miss them completely.

PCR is like finding a single strand of their hair at the crime scene and cloning it a million times until the DNA evidence is undeniable.

Because PCR is vastly more sensitive, you can use it on non -blistering lesions with incredible accuracy.

That makes perfect sense, like a high -def camera versus a blurry Polaroid.

That's a perfect analogy.

Also, if you are ordering blood work to check for a past herpes infection, the gold standard is type -specific IgG antibody testing,

which shows seroconversion about four months after exposure.

You really should avoid ordering an IgM test for herpes as it is highly nonspecific and prone to false positives.

Good to know.

Once we have our definitive pathogen, we initiate pharmacological management.

Let's look at the heavy hitters from the table in the text.

For glimidia, the recommended regimen for adults is doxycycline, 100 milligrams orally, twice a day for seven days.

But there is a massive biological safety precaution here.

Yes.

Doxycycline binds aggressively to calcium.

Because of this mechanism, it is strictly contraindicated during the second and third trimesters of pregnancy.

Wait, really?

What happens?

If a pregnant patient takes it, the drug literally binds to the developing calcium in the fetus's teeth and bones, causing permanent discoloration and skeletal growth issues.

For pregnant patients, you have to pivot to azithromycin, one gram orally in a single dose instead.

That is a crucial save.

For gonorrhea and PID, we rely on ceftriaxone, administered intramuscularly, usually as a 500 -milligram single dose.

And here is a clinical pearl to make your patients love you.

You can dilute that ceftriaxone injection with 1 % lidocaine.

Oh, absolutely do that.

Right.

It significantly reduces the intense burning pain of the injection, which really builds patient trust and compliance.

Definitely.

And for syphilis, the treatment for primary, secondary, and early latent stages is benzotine penicillin G, 2 .4 million units IM in a single dose.

But you must thoroughly educate your patient about the Jerrish -Herxheimer reaction, before they leave the clinic.

Right.

Because imagine a patient getting that penicillin shot, going home feeling fine, and then calling the on -call clinic phone at 2 a .m., absolutely terrified.

Because they suddenly have a spiking fever, a counting headache, and severe muscle aches.

If you don't warn them, they'll head straight to an ER, mistakenly convinced they're experiencing a lethal allergic reaction to penicillin.

Exactly.

Yeah.

You prevent that panic by explaining the biology beforehand.

You tell them that the penicillin is highly effective, and as it rapidly destroys the spirochete bacteria, those dying bacteria burst open.

Oh, wow.

Yeah.

And they release large amounts of toxins and inflammatory cytokines into the bloodstream all at once.

The fever and aches are an expected temporary immune response to the massive bacterial die -off, not an allergy.

Okay.

So let's put it all together and test these concepts by walking through the real clinical case study provided in the chapter.

You are evaluating a 23 -year -old female presenting to the office complaining of yellow discharge with an odor and vaginal irritation that started two weeks ago.

Okay.

She tried an over -the -counter fungal cream for three days with no improvement.

She denies pain with urination, pelvic pain, or any visible sores.

We begin by analyzing her risk factors from the history.

She has a new male partner for the last four months, and a total of two partners in the past year.

Crucially, they engage in vaginal sex with zero condom use.

She has a history of a chlamydia infection two years ago, and her current medication is a levonorgestrel intranor device.

So she is under 25, has a new partner, doesn't use barrier protection, and has a prior STI history.

She is solidly in a high -risk category.

You move to the physical exam.

Her vital signs are completely normal.

Blood pressure 1, 12 over 78, temperature 98 .6, no fever.

On the pelvic exam, her external genitalia are red and inflamed, but there are no lesions.

Inside the vagina, you see a frothy yellow discharge with that distinct fishy odor we talked about.

Her cervix is red, but not bleeding.

And most importantly, on the bimanual exam, she has absolutely no cervical motion tenderness or tenderness in the adnexa.

So the clinical reasoning here is about ruling out the most dangerous possibilities first.

The complete lack of cervical motion tenderness is a vital piece of data.

It effectively rules out a severe upper tract infection like PID.

We can also likely rule out a simple yeast infection, not only because the fungal cream failed, but because yeast typically presents with a thick, white, clumpy discharge and lacks a foul odor.

Based on the unprotected sex with a new partner, combined with the frothy yellow discharge and the amine odor, the presentation heavily points to trachomoniasis.

We suspect the swimming protozoan.

To prove it, we order a gnat for Trachomonas vaginalis using a vaginal swab, because we know the DNA amplification is highly sensitive.

If you only have a microscope in the clinic, you could do a wet mount to look for the motile parasites visually, but the sensitivity is much lower.

Given her high -risk profile, we also offer concurrent testing for chlamydia, gonorrhea, HIV, and syphilis.

And let's say the gnat comes back positive for trachomoniasis.

The recommended treatment regimen is metronidazole, 500 mg orally, twice daily for 7 days.

Wait, this brings up a massive piece of laicin knowledge.

Students are often taught that you absolutely cannot mix metronidazole with alcohol, or the patient will suffer a violent disulfiram -like reaction with severe vomiting.

Right, that has been taught for decades.

But the clinical medicine has evolved.

Refraining from alcohol use while taking metronidazole is actually considered unnecessary based on current CDC guidelines.

Really?

Yeah, the data simply does not support the risk of a severe reaction.

This is exactly why continually updating your clinical knowledge with texts like this is so vital.

That is wild.

Okay, so we give her the medication, but our job isn't finished until we handle the patient education.

You must treat the partner to prevent a ping pong effect of reinfection.

You offer expedited partner therapy, meaning you write a prescription for her partner without legally needing to examine them first, provided it aligns with your specific state laws.

You counsel her to completely abstain from sex until both she and her partner have completed the medication and all symptoms have resolved.

Because trichomoniasis has notoriously high reinfection rates, follow -up is critical.

The current guideline is to retest her in three months.

If she misses that specific appointment, you ensure she is retested whenever she presents for any medical care in the 12 months following her initial treatment.

You know, when you step back and look at the entire process, from identifying the biological vulnerability to the targeted history, the physical exam, the precise diagnostics, and the final education, you realize the gravity of the role.

When you properly assess a patient using these clinical steps, you are actively preserving their systemic health and their future ability to build a family by catching microscopic threats they cannot even feel.

Which leaves you with a final thought to mull over as you head out onto the clinic floor.

We discussed the staggering 111 % increase in gonorrhea cases and the pathogen's ability to mutate and develop widespread fluoroquinolone resistance.

As bacteria continue to evolve, what happens to women's health when these silent infections completely outpace our current antibiotic arsenal?

That's a scary thought.

How will you, as the next generation of advanced practice clinicians, lead the charge in screening, prevention, and patient care in a post -antibiotic landscape?

The clinical landscape is shifting rapidly, and the detective skills you refine today will be your greatest asset tomorrow.

On behalf of the Last Minute Lecture team, thank you so much for joining us for this deep dive.

Good luck on your exams and good luck in your clinicals.

Keep listening for the silent alarms.

We will see you next time.